The global Microarray Patch Vaccine market was valued at US$ 22.15 million in 2025 and is anticipated to reach US$ 37.48 million by 2032, at a CAGR of 7.8% from 2026 to 2032.

Microarray Patch Vaccine Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Microarray Patch Vaccine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

A microarray patch vaccine is a needle-free vaccination technology that delivers vaccine antigens through the skin using a small patch covered with hundreds to thousands of microscopic projections. When the patch is pressed onto the skin, these micro-projections painlessly penetrate the outer skin layer and deposit the vaccine into immune-cell-rich regions, triggering a strong immune response with very small doses. Microarray patch vaccines can be solid-coated, dissolving, or hollow, and many designs eliminate sharps waste and reduce the need for trained healthcare workers. Because they are often more thermostable than traditional injectable vaccines and easier to administer, microarray patch vaccines are seen as a promising approach for mass immunization, pandemic response, and vaccination in low-resource or remote settings. Microarray patch vaccine cost between $0.85 and $5.00 per dose/patch.

Microarray patch vaccines are manufactured through a combination of vaccine drug-product and microfabricated device supply chains. Upstream, the process starts with vaccine antigen production (cell culture/fermentation or recombinant expression), followed by purification and formulation with stabilizing excipients (e.g., sugars, polymers, buffers, surfactants, sometimes adjuvants) designed to preserve potency during drying and storage; in parallel, suppliers provide microneedle array materials (dissolving polymers/sugars or solid substrates), precision tooling (micro-molds/etching), medical-grade backings/adhesives/liners, and moisture-barrier packaging components. Midstream manufacturing typically includes forming the microarray (molding/etching), loading antigen into tips or coating the projections, controlled drying/curing under tight humidity control, patch assembly/lamination (and sometimes an applicator), then stringent QC/QA for dose uniformity, mechanical insertion performance, sterility/bioburden strategy, and stability. Downstream, Microarray patch vaccines move through a “combination product” distribution model—often emphasizing humidity-protected primary packs and validated shipping—into immunization channels such as national programs, clinics, pharmacies, or outreach campaigns, where the patch is applied for a specified dwell time and then disposed of (with reduced sharps handling for dissolving designs), with training, traceability, and pharmacovigilance integrated similarly to conventional vaccines.

The North American market for Microarray Patch Vaccine is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Microarray Patch Vaccine is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

Major global manufacturers of Microarray Patch Vaccine include Kindeva, Raphas, CosMED Pharmaceutical, Vaxess Technologies, Micron Biomedical, LTS Lohmann Therapie-Systeme, ArrayPatch, CeraVx, Zhongke Microneedle (Beijing) Technology, Zhuhai Youwe Biotechnology, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Microarray Patch Vaccine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Microarray Patch Vaccine. The Microarray Patch Vaccine market size, estimates, and forecasts are provided in terms of sales volume (K Pcs) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Microarray Patch Vaccine market comprehensively. Regional market sizes by Type, by Application, by Microneedle Material, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Microarray Patch Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Microarray Patch Vaccine Market Report

Report Metric	Details
Report Name	Microarray Patch Vaccine Market
Accounted market size in 2025	US$ 22.15 million
Forecasted market size in 2032	US$ 37.48 million
CAGR	7.8%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Dissolving Non-dissolving
Segment by Microneedle Material	Hyaluronic Acid Taurine Triple-helical Collagen
Segment by Form of Use	Patches Direct Topical
by Application	Routine Childhood Immunization Adolescent / Pre-adolescent Prevention Travel / Endemic Exposure / Post-exposure Respiratory Vaccines with Recurring Demand Outbreak / Pandemic Preparedness
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Kindeva, Raphas, CosMED Pharmaceutical, Vaxess Technologies, Micron Biomedical, LTS Lohmann Therapie-Systeme, ArrayPatch, CeraVx, Zhongke Microneedle (Beijing) Technology, Zhuhai Youwe Biotechnology, Youwei (Zhuhai) Biotechnology, WCC Biomedical, Hisamitsu Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Microneedle Material, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Microarray Patch Vaccine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Microarray Patch Vaccine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Microarray Patch Vaccine Market growing?

Ans: The Microarray Patch Vaccine Market witnessing a CAGR of 7.8% during the forecast period 2026-2032.

What is the Microarray Patch Vaccine Market size in 2032?

Ans: The Microarray Patch Vaccine Market size in 2032 will be US$ 37.48 million.

Who are the main players in the Microarray Patch Vaccine Market report?

Ans: The main players in the Microarray Patch Vaccine Market are Kindeva, Raphas, CosMED Pharmaceutical, Vaxess Technologies, Micron Biomedical, LTS Lohmann Therapie-Systeme, ArrayPatch, CeraVx, Zhongke Microneedle (Beijing) Technology, Zhuhai Youwe Biotechnology, Youwei (Zhuhai) Biotechnology, WCC Biomedical, Hisamitsu Pharmaceutical

What are the Application segmentation covered in the Microarray Patch Vaccine Market report?

Ans: The Applications covered in the Microarray Patch Vaccine Market report are Routine Childhood Immunization, Adolescent / Pre-adolescent Prevention, Travel / Endemic Exposure / Post-exposure, Respiratory Vaccines with Recurring Demand, Outbreak / Pandemic Preparedness

What are the Type segmentation covered in the Microarray Patch Vaccine Market report?

Ans: The Types covered in the Microarray Patch Vaccine Market report are Dissolving, Non-dissolving

1 Microarray Patch Vaccine Market Overview

1.1 Product Definition

1.2 Microarray Patch Vaccine by Type

1.2.1 Global Microarray Patch Vaccine Market Value by Type: 2025 vs 2032

1.2.2 Dissolving

1.2.3 Non-dissolving

1.3 Microarray Patch Vaccine by Microneedle Material

1.3.1 Global Microarray Patch Vaccine Market Value by Microneedle Material: 2025 vs 2032

1.3.2 Hyaluronic Acid

1.3.3 Taurine

1.3.4 Triple-helical Collagen

1.4 Microarray Patch Vaccine by Form of Use

1.4.1 Global Microarray Patch Vaccine Market Value by Form of Use: 2025 vs 2032

1.4.2 Patches

1.4.3 Direct Topical

1.5 Microarray Patch Vaccine by Application

1.5.1 Global Microarray Patch Vaccine Market Value by Application: 2025 vs 2032

1.5.2 Routine Childhood Immunization

1.5.3 Adolescent / Pre-adolescent Prevention

1.5.4 Travel / Endemic Exposure / Post-exposure

1.5.5 Respiratory Vaccines with Recurring Demand

1.5.6 Outbreak / Pandemic Preparedness

1.6 Global Microarray Patch Vaccine Market Size Estimates and Forecasts

1.6.1 Global Microarray Patch Vaccine Revenue 2021–2032

1.6.2 Global Microarray Patch Vaccine Sales 2021–2032

1.6.3 Global Microarray Patch Vaccine Market Average Price (2021–2032)

1.7 Assumptions and Limitations

2 Microarray Patch Vaccine Market Competition by Manufacturers

2.1 Global Microarray Patch Vaccine Sales Market Share by Manufacturers (2021–2026)

2.2 Global Microarray Patch Vaccine Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Microarray Patch Vaccine Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Microarray Patch Vaccine, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Microarray Patch Vaccine, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Microarray Patch Vaccine, Product Types and Applications

2.7 Global Key Manufacturers of Microarray Patch Vaccine, Date of Entry into the Industry

2.8 Global Microarray Patch Vaccine Market Competitive Situation and Trends

2.8.1 Global Microarray Patch Vaccine Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Microarray Patch Vaccine Players Market Share by Revenue

2.8.3 Global Microarray Patch Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Microarray Patch Vaccine Market Scenario by Region

3.1 Global Microarray Patch Vaccine Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Microarray Patch Vaccine Sales by Region: 2021–2032

3.2.1 Global Microarray Patch Vaccine Sales by Region: 2021–2026

3.2.2 Global Microarray Patch Vaccine Sales by Region: 2027–2032

3.3 Global Microarray Patch Vaccine Revenue by Region: 2021–2032

3.3.1 Global Microarray Patch Vaccine Revenue by Region: 2021–2026

3.3.2 Global Microarray Patch Vaccine Revenue by Region: 2027–2032

3.4 North America Microarray Patch Vaccine Market Facts & Figures by Country

3.4.1 North America Microarray Patch Vaccine Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Microarray Patch Vaccine Sales by Country (2021–2032)

3.4.3 North America Microarray Patch Vaccine Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Microarray Patch Vaccine Market Facts & Figures by Country

3.5.1 Europe Microarray Patch Vaccine Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Microarray Patch Vaccine Sales by Country (2021–2032)

3.5.3 Europe Microarray Patch Vaccine Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Microarray Patch Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific Microarray Patch Vaccine Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Microarray Patch Vaccine Sales by Region (2021–2032)

3.6.3 Asia Pacific Microarray Patch Vaccine Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Microarray Patch Vaccine Market Facts & Figures by Country

3.7.1 Latin America Microarray Patch Vaccine Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Microarray Patch Vaccine Sales by Country (2021–2032)

3.7.3 Latin America Microarray Patch Vaccine Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Microarray Patch Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Microarray Patch Vaccine Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Microarray Patch Vaccine Sales by Country (2021–2032)

3.8.3 Middle East and Africa Microarray Patch Vaccine Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Microarray Patch Vaccine Sales by Type (2021–2032)

4.1.1 Global Microarray Patch Vaccine Sales by Type (2021–2026)

4.1.2 Global Microarray Patch Vaccine Sales by Type (2027–2032)

4.1.3 Global Microarray Patch Vaccine Sales Market Share by Type (2021–2032)

4.2 Global Microarray Patch Vaccine Revenue by Type (2021–2032)

4.2.1 Global Microarray Patch Vaccine Revenue by Type (2021–2026)

4.2.2 Global Microarray Patch Vaccine Revenue by Type (2027–2032)

4.2.3 Global Microarray Patch Vaccine Revenue Market Share by Type (2021–2032)

4.3 Global Microarray Patch Vaccine Price by Type (2021–2032)

5 Segment by Application

5.1 Global Microarray Patch Vaccine Sales by Application (2021–2032)

5.1.1 Global Microarray Patch Vaccine Sales by Application (2021–2026)

5.1.2 Global Microarray Patch Vaccine Sales by Application (2027–2032)

5.1.3 Global Microarray Patch Vaccine Sales Market Share by Application (2021–2032)

5.2 Global Microarray Patch Vaccine Revenue by Application (2021–2032)

5.2.1 Global Microarray Patch Vaccine Revenue by Application (2021–2026)

5.2.2 Global Microarray Patch Vaccine Revenue by Application (2027–2032)

5.2.3 Global Microarray Patch Vaccine Revenue Market Share by Application (2021–2032)

5.3 Global Microarray Patch Vaccine Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Kindeva

6.1.1 Kindeva Company Information

6.1.2 Kindeva Description and Business Overview

6.1.3 Kindeva Microarray Patch Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Kindeva Microarray Patch Vaccine Product Portfolio

6.1.5 Kindeva Recent Developments/Updates

6.2 Raphas

6.2.1 Raphas Company Information

6.2.2 Raphas Description and Business Overview

6.2.3 Raphas Microarray Patch Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Raphas Microarray Patch Vaccine Product Portfolio

6.2.5 Raphas Recent Developments/Updates

6.3 CosMED Pharmaceutical

6.3.1 CosMED Pharmaceutical Company Information

6.3.2 CosMED Pharmaceutical Description and Business Overview

6.3.3 CosMED Pharmaceutical Microarray Patch Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 CosMED Pharmaceutical Microarray Patch Vaccine Product Portfolio

6.3.5 CosMED Pharmaceutical Recent Developments/Updates

6.4 Vaxess Technologies

6.4.1 Vaxess Technologies Company Information

6.4.2 Vaxess Technologies Description and Business Overview

6.4.3 Vaxess Technologies Microarray Patch Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Vaxess Technologies Microarray Patch Vaccine Product Portfolio

6.4.5 Vaxess Technologies Recent Developments/Updates

6.5 Micron Biomedical

6.5.1 Micron Biomedical Company Information

6.5.2 Micron Biomedical Description and Business Overview

6.5.3 Micron Biomedical Microarray Patch Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Micron Biomedical Microarray Patch Vaccine Product Portfolio

6.5.5 Micron Biomedical Recent Developments/Updates

6.6 LTS Lohmann Therapie-Systeme

6.6.1 LTS Lohmann Therapie-Systeme Company Information

6.6.2 LTS Lohmann Therapie-Systeme Description and Business Overview

6.6.3 LTS Lohmann Therapie-Systeme Microarray Patch Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 LTS Lohmann Therapie-Systeme Microarray Patch Vaccine Product Portfolio

6.6.5 LTS Lohmann Therapie-Systeme Recent Developments/Updates

6.7 ArrayPatch

6.7.1 ArrayPatch Company Information

6.7.2 ArrayPatch Description and Business Overview

6.7.3 ArrayPatch Microarray Patch Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 ArrayPatch Microarray Patch Vaccine Product Portfolio

6.7.5 ArrayPatch Recent Developments/Updates

6.8 CeraVx

6.8.1 CeraVx Company Information

6.8.2 CeraVx Description and Business Overview

6.8.3 CeraVx Microarray Patch Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 CeraVx Microarray Patch Vaccine Product Portfolio

6.8.5 CeraVx Recent Developments/Updates

6.9 Zhongke Microneedle (Beijing) Technology

6.9.1 Zhongke Microneedle (Beijing) Technology Company Information

6.9.2 Zhongke Microneedle (Beijing) Technology Description and Business Overview

6.9.3 Zhongke Microneedle (Beijing) Technology Microarray Patch Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Zhongke Microneedle (Beijing) Technology Microarray Patch Vaccine Product Portfolio

6.9.5 Zhongke Microneedle (Beijing) Technology Recent Developments/Updates

6.10 Zhuhai Youwe Biotechnology

6.10.1 Zhuhai Youwe Biotechnology Company Information

6.10.2 Zhuhai Youwe Biotechnology Description and Business Overview

6.10.3 Zhuhai Youwe Biotechnology Microarray Patch Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.10.4 Zhuhai Youwe Biotechnology Microarray Patch Vaccine Product Portfolio

6.10.5 Zhuhai Youwe Biotechnology Recent Developments/Updates

6.11 Youwei (Zhuhai) Biotechnology

6.11.1 Youwei (Zhuhai) Biotechnology Company Information

6.11.2 Youwei (Zhuhai) Biotechnology Description and Business Overview

6.11.3 Youwei (Zhuhai) Biotechnology Microarray Patch Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.11.4 Youwei (Zhuhai) Biotechnology Microarray Patch Vaccine Product Portfolio

6.11.5 Youwei (Zhuhai) Biotechnology Recent Developments/Updates

6.12 WCC Biomedical

6.12.1 WCC Biomedical Company Information

6.12.2 WCC Biomedical Description and Business Overview

6.12.3 WCC Biomedical Microarray Patch Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.12.4 WCC Biomedical Microarray Patch Vaccine Product Portfolio

6.12.5 WCC Biomedical Recent Developments/Updates

6.13 Hisamitsu Pharmaceutical

6.13.1 Hisamitsu Pharmaceutical Company Information

6.13.2 Hisamitsu Pharmaceutical Description and Business Overview

6.13.3 Hisamitsu Pharmaceutical Microarray Patch Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.13.4 Hisamitsu Pharmaceutical Microarray Patch Vaccine Product Portfolio

6.13.5 Hisamitsu Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Microarray Patch Vaccine Industry Chain Analysis

7.2 Microarray Patch Vaccine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Microarray Patch Vaccine Production Mode & Process Analysis

7.4 Microarray Patch Vaccine Sales and Marketing

7.4.1 Microarray Patch Vaccine Sales Channels

7.4.2 Microarray Patch Vaccine Distributors

7.5 Microarray Patch Vaccine Customer Analysis

8 Microarray Patch Vaccine Market Dynamics

8.1 Microarray Patch Vaccine Industry Trends

8.2 Microarray Patch Vaccine Market Drivers

8.3 Microarray Patch Vaccine Market Challenges

8.4 Microarray Patch Vaccine Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

KINDEVA

Raphas

Cosmed Pharmaceutical

Vaxess Technologies

Micron Biomedical

LTS Lohmann Therapie-Systeme

ArrayPatch

CeraVx

Zhongke Microneedle (Beijing) Technology

Zhuhai Youwe Biotechnology

Youwei (Zhuhai) Biotechnology

WCC Biomedical

Hisamitsu Pharmaceutical

List of Tables

Table 1. Global Microarray Patch Vaccine Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Microarray Patch Vaccine Market Value by Microneedle Material (US$ Million), 2025 vs 2032

Table 3. Global Microarray Patch Vaccine Market Value by Form of Use (US$ Million), 2025 vs 2032

Table 4. Global Microarray Patch Vaccine Market Value by Application (US$ Million), 2025 vs 2032

Table 5. Global Microarray Patch Vaccine Market Competitive Situation by Manufacturers in 2025

Table 6. Global Microarray Patch Vaccine Sales (K Pcs) of Key Manufacturers (2021–2026)

Table 7. Global Microarray Patch Vaccine Sales Market Share by Manufacturers (2021–2026)

Table 8. Global Microarray Patch Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)

Table 9. Global Microarray Patch Vaccine Revenue Share by Manufacturers (2021–2026)

Table 10. Global Market Microarray Patch Vaccine Average Price (US$/Pc) of Key Manufacturers (2021–2026)

Table 11. Global Key Players of Microarray Patch Vaccine, Industry Ranking, 2023 vs 2024 vs 2025

Table 12. Global Key Manufacturers of Microarray Patch Vaccine, Manufacturing Sites and Headquarters

Table 13. Global Key Manufacturers of Microarray Patch Vaccine, Product Types and Applications

Table 14. Global Key Manufacturers of Microarray Patch Vaccine, Date of Entry into the Industry

Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 16. Global Microarray Patch Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Microarray Patch Vaccine Revenue, 2025

Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 18. Global Microarray Patch Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 19. Global Microarray Patch Vaccine Sales by Region (K Pcs), 2021–2026

Table 20. Global Microarray Patch Vaccine Sales Market Share by Region (2021–2026)

Table 21. Global Microarray Patch Vaccine Sales by Region (K Pcs), 2027–2032

Table 22. Global Microarray Patch Vaccine Sales Market Share by Region (2027–2032)

Table 23. Global Microarray Patch Vaccine Revenue by Region (US$ Million), 2021–2026

Table 24. Global Microarray Patch Vaccine Revenue Market Share by Region (2021–2026)

Table 25. Global Microarray Patch Vaccine Revenue by Region (US$ Million), 2027–2032

Table 26. Global Microarray Patch Vaccine Revenue Market Share by Region (2027–2032)

Table 27. North America Microarray Patch Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 28. North America Microarray Patch Vaccine Sales by Country (K Pcs), 2021–2026

Table 29. North America Microarray Patch Vaccine Sales by Country (K Pcs), 2027–2032

Table 30. North America Microarray Patch Vaccine Revenue by Country (US$ Million), 2021–2026

Table 31. North America Microarray Patch Vaccine Revenue by Country (US$ Million), 2027–2032

Table 32. Europe Microarray Patch Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 33. Europe Microarray Patch Vaccine Sales by Country (K Pcs), 2021–2026

Table 34. Europe Microarray Patch Vaccine Sales by Country (K Pcs), 2027–2032

Table 35. Europe Microarray Patch Vaccine Revenue by Country (US$ Million), 2021–2026

Table 36. Europe Microarray Patch Vaccine Revenue by Country (US$ Million), 2027–2032

Table 37. Asia Pacific Microarray Patch Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 38. Asia Pacific Microarray Patch Vaccine Sales by Region (K Pcs), 2021–2026

Table 39. Asia Pacific Microarray Patch Vaccine Sales by Region (K Pcs), 2027–2032

Table 40. Asia Pacific Microarray Patch Vaccine Revenue by Region (US$ Million), 2021–2026

Table 41. Asia Pacific Microarray Patch Vaccine Revenue by Region (US$ Million), 2027–2032

Table 42. Latin America Microarray Patch Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 43. Latin America Microarray Patch Vaccine Sales by Country (K Pcs), 2021–2026

Table 44. Latin America Microarray Patch Vaccine Sales by Country (K Pcs), 2027–2032

Table 45. Latin America Microarray Patch Vaccine Revenue by Country (US$ Million), 2021–2026

Table 46. Latin America Microarray Patch Vaccine Revenue by Country (US$ Million), 2027–2032

Table 47. Middle East and Africa Microarray Patch Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 48. Middle East and Africa Microarray Patch Vaccine Sales by Country (K Pcs), 2021–2026

Table 49. Middle East and Africa Microarray Patch Vaccine Sales by Country (K Pcs), 2027–2032

Table 50. Middle East and Africa Microarray Patch Vaccine Revenue by Country (US$ Million), 2021–2026

Table 51. Middle East and Africa Microarray Patch Vaccine Revenue by Country (US$ Million), 2027–2032

Table 52. Global Microarray Patch Vaccine Sales (K Pcs) by Type (2021–2026)

Table 53. Global Microarray Patch Vaccine Sales (K Pcs) by Type (2027–2032)

Table 54. Global Microarray Patch Vaccine Sales Market Share by Type (2021–2026)

Table 55. Global Microarray Patch Vaccine Sales Market Share by Type (2027–2032)

Table 56. Global Microarray Patch Vaccine Revenue (US$ Million) by Type (2021–2026)

Table 57. Global Microarray Patch Vaccine Revenue (US$ Million) by Type (2027–2032)

Table 58. Global Microarray Patch Vaccine Revenue Market Share by Type (2021–2026)

Table 59. Global Microarray Patch Vaccine Revenue Market Share by Type (2027–2032)

Table 60. Global Microarray Patch Vaccine Price (US$/Pc) by Type (2021–2026)

Table 61. Global Microarray Patch Vaccine Price (US$/Pc) by Type (2027–2032)

Table 62. Global Microarray Patch Vaccine Sales (K Pcs) by Application (2021–2026)

Table 63. Global Microarray Patch Vaccine Sales (K Pcs) by Application (2027–2032)

Table 64. Global Microarray Patch Vaccine Sales Market Share by Application (2021–2026)

Table 65. Global Microarray Patch Vaccine Sales Market Share by Application (2027–2032)

Table 66. Global Microarray Patch Vaccine Revenue (US$ Million) by Application (2021–2026)

Table 67. Global Microarray Patch Vaccine Revenue (US$ Million) by Application (2027–2032)

Table 68. Global Microarray Patch Vaccine Revenue Market Share by Application (2021–2026)

Table 69. Global Microarray Patch Vaccine Revenue Market Share by Application (2027–2032)

Table 70. Global Microarray Patch Vaccine Price (US$/Pc) by Application (2021–2026)

Table 71. Global Microarray Patch Vaccine Price (US$/Pc) by Application (2027–2032)

Table 72. Kindeva Company Information

Table 73. Kindeva Description and Business Overview

Table 74. Kindeva Microarray Patch Vaccine Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)

Table 75. Kindeva Microarray Patch Vaccine Product

Table 76. Kindeva Recent Developments/Updates

Table 77. Raphas Company Information

Table 78. Raphas Description and Business Overview

Table 79. Raphas Microarray Patch Vaccine Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)

Table 80. Raphas Microarray Patch Vaccine Product

Table 81. Raphas Recent Developments/Updates

Table 82. CosMED Pharmaceutical Company Information

Table 83. CosMED Pharmaceutical Description and Business Overview

Table 84. CosMED Pharmaceutical Microarray Patch Vaccine Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)

Table 85. CosMED Pharmaceutical Microarray Patch Vaccine Product

Table 86. CosMED Pharmaceutical Recent Developments/Updates

Table 87. Vaxess Technologies Company Information

Table 88. Vaxess Technologies Description and Business Overview

Table 89. Vaxess Technologies Microarray Patch Vaccine Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)

Table 90. Vaxess Technologies Microarray Patch Vaccine Product

Table 91. Vaxess Technologies Recent Developments/Updates

Table 92. Micron Biomedical Company Information

Table 93. Micron Biomedical Description and Business Overview

Table 94. Micron Biomedical Microarray Patch Vaccine Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)

Table 95. Micron Biomedical Microarray Patch Vaccine Product

Table 96. Micron Biomedical Recent Developments/Updates

Table 97. LTS Lohmann Therapie-Systeme Company Information

Table 98. LTS Lohmann Therapie-Systeme Description and Business Overview

Table 99. LTS Lohmann Therapie-Systeme Microarray Patch Vaccine Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)

Table 100. LTS Lohmann Therapie-Systeme Microarray Patch Vaccine Product

Table 101. LTS Lohmann Therapie-Systeme Recent Developments/Updates

Table 102. ArrayPatch Company Information

Table 103. ArrayPatch Description and Business Overview

Table 104. ArrayPatch Microarray Patch Vaccine Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)

Table 105. ArrayPatch Microarray Patch Vaccine Product

Table 106. ArrayPatch Recent Developments/Updates

Table 107. CeraVx Company Information

Table 108. CeraVx Description and Business Overview

Table 109. CeraVx Microarray Patch Vaccine Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)

Table 110. CeraVx Microarray Patch Vaccine Product

Table 111. CeraVx Recent Developments/Updates

Table 112. Zhongke Microneedle (Beijing) Technology Company Information

Table 113. Zhongke Microneedle (Beijing) Technology Description and Business Overview

Table 114. Zhongke Microneedle (Beijing) Technology Microarray Patch Vaccine Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)

Table 115. Zhongke Microneedle (Beijing) Technology Microarray Patch Vaccine Product

Table 116. Zhongke Microneedle (Beijing) Technology Recent Developments/Updates

Table 117. Zhuhai Youwe Biotechnology Company Information

Table 118. Zhuhai Youwe Biotechnology Description and Business Overview

Table 119. Zhuhai Youwe Biotechnology Microarray Patch Vaccine Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)

Table 120. Zhuhai Youwe Biotechnology Microarray Patch Vaccine Product

Table 121. Zhuhai Youwe Biotechnology Recent Developments/Updates

Table 122. Youwei (Zhuhai) Biotechnology Company Information

Table 123. Youwei (Zhuhai) Biotechnology Description and Business Overview

Table 124. Youwei (Zhuhai) Biotechnology Microarray Patch Vaccine Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)

Table 125. Youwei (Zhuhai) Biotechnology Microarray Patch Vaccine Product

Table 126. Youwei (Zhuhai) Biotechnology Recent Developments/Updates

Table 127. WCC Biomedical Company Information

Table 128. WCC Biomedical Description and Business Overview

Table 129. WCC Biomedical Microarray Patch Vaccine Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)

Table 130. WCC Biomedical Microarray Patch Vaccine Product

Table 131. WCC Biomedical Recent Developments/Updates

Table 132. Hisamitsu Pharmaceutical Company Information

Table 133. Hisamitsu Pharmaceutical Description and Business Overview

Table 134. Hisamitsu Pharmaceutical Microarray Patch Vaccine Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)

Table 135. Hisamitsu Pharmaceutical Microarray Patch Vaccine Product

Table 136. Hisamitsu Pharmaceutical Recent Developments/Updates

Table 137. Key Raw Materials Lists

Table 138. Raw Materials Key Suppliers Lists

Table 139. Microarray Patch Vaccine Distributors List

Table 140. Microarray Patch Vaccine Customers List

Table 141. Microarray Patch Vaccine Market Trends

Table 142. Microarray Patch Vaccine Market Drivers

Table 143. Microarray Patch Vaccine Market Challenges

Table 144. Microarray Patch Vaccine Market Restraints

Table 145. Research Programs/Design for This Report

Table 146. Key Data Information from Secondary Sources

Table 147. Key Data Information from Primary Sources

Table 148. Authors List of This Report

List of Figures

Figure 1. Product Picture of Microarray Patch Vaccine

Figure 2. Global Microarray Patch Vaccine Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Microarray Patch Vaccine Market Share by Type: 2025 & 2032

Figure 4. Dissolving Product Picture

Figure 5. Non-dissolving Product Picture

Figure 6. Global Microarray Patch Vaccine Market Value by Microneedle Material (US$ Million), 2021–2032

Figure 7. Global Microarray Patch Vaccine Market Share by Microneedle Material: 2025 vs 2032

Figure 8. Hyaluronic Acid Product Picture

Figure 9. Taurine Product Picture

Figure 10. Triple-helical Collagen Product Picture

Figure 11. Global Microarray Patch Vaccine Market Value by Form of Use (US$ Million), 2021–2032

Figure 12. Global Microarray Patch Vaccine Market Share by Form of Use: 2025 vs 2032

Figure 13. Patches Product Picture

Figure 14. Direct Topical Product Picture

Figure 15. Global Microarray Patch Vaccine Market Value by Application (US$ Million), 2021–2032

Figure 16. Global Microarray Patch Vaccine Market Share by Application: 2025 & 2032

Figure 17. Routine Childhood Immunization

Figure 18. Adolescent / Pre-adolescent Prevention

Figure 19. Travel / Endemic Exposure / Post-exposure

Figure 20. Respiratory Vaccines with Recurring Demand

Figure 21. Outbreak / Pandemic Preparedness

Figure 22. Global Microarray Patch Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 23. Global Microarray Patch Vaccine Market Size (US$ Million), 2021–2032

Figure 24. Global Microarray Patch Vaccine Sales (K Pcs), 2021–2032

Figure 25. Global Microarray Patch Vaccine Average Price (US$/Pc), 2021–2032

Figure 26. Microarray Patch Vaccine Report Years Considered

Figure 27. Microarray Patch Vaccine Sales Share by Manufacturers in 2025

Figure 28. Global Microarray Patch Vaccine Revenue Share by Manufacturers in 2025

Figure 29. Top 5 and Top 10 Global Microarray Patch Vaccine Players: Market Share by Revenue in Microarray Patch Vaccine in 2025

Figure 30. Microarray Patch Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 31. Global Microarray Patch Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 32. North America Microarray Patch Vaccine Sales Market Share by Country (2021–2032)

Figure 33. North America Microarray Patch Vaccine Revenue Market Share by Country (2021–2032)

Figure 34. United States Microarray Patch Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. Canada Microarray Patch Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. Europe Microarray Patch Vaccine Sales Market Share by Country (2021–2032)

Figure 37. Europe Microarray Patch Vaccine Revenue Market Share by Country (2021–2032)

Figure 38. Germany Microarray Patch Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. France Microarray Patch Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. U.K. Microarray Patch Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Italy Microarray Patch Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Russia Microarray Patch Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Asia Pacific Microarray Patch Vaccine Sales Market Share by Region (2021–2032)

Figure 44. Asia Pacific Microarray Patch Vaccine Revenue Market Share by Region (2021–2032)

Figure 45. China Microarray Patch Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Japan Microarray Patch Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. South Korea Microarray Patch Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. India Microarray Patch Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Australia Microarray Patch Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. China Taiwan Microarray Patch Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Southeast Asia Microarray Patch Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Latin America Microarray Patch Vaccine Sales Market Share by Country (2021–2032)

Figure 53. Latin America Microarray Patch Vaccine Revenue Market Share by Country (2021–2032)

Figure 54. Mexico Microarray Patch Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 55. Brazil Microarray Patch Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 56. Argentina Microarray Patch Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 57. Colombia Microarray Patch Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 58. Middle East and Africa Microarray Patch Vaccine Sales Market Share by Country (2021–2032)

Figure 59. Middle East and Africa Microarray Patch Vaccine Revenue Market Share by Country (2021–2032)

Figure 60. Turkey Microarray Patch Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 61. Saudi Arabia Microarray Patch Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 62. UAE Microarray Patch Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 63. Global Sales Market Share of Microarray Patch Vaccine by Type (2021–2032)

Figure 64. Global Revenue Market Share of Microarray Patch Vaccine by Type (2021–2032)

Figure 65. Global Microarray Patch Vaccine Price (US$/Pc) by Type (2021–2032)

Figure 66. Global Sales Market Share of Microarray Patch Vaccine by Application (2021–2032)

Figure 67. Global Revenue Market Share of Microarray Patch Vaccine by Application (2021–2032)

Figure 68. Global Microarray Patch Vaccine Price (US$/Pc) by Application (2021–2032)

Figure 69. Microarray Patch Vaccine Value Chain

Figure 70. Channels of Distribution (Direct Vs Distribution)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Microarray Patch Vaccine Market Research Report 2026

Published Date: 2026-02-10

Report Code: QYRE-Auto-23E19804

Global Microarray Patch Vaccine Market Research Report 2026

FEATURED COMPANIES

Microarray Patch Vaccine Market Size

Microarray Patch Vaccine Market

Scope of Microarray Patch Vaccine Market Report

Chapter Outline

FAQ for this report

How fast is Microarray Patch Vaccine Market growing?

What is the Microarray Patch Vaccine Market size in 2032?

Who are the main players in the Microarray Patch Vaccine Market report?

What are the Application segmentation covered in the Microarray Patch Vaccine Market report?

What are the Type segmentation covered in the Microarray Patch Vaccine Market report?

FEATURED COMPANIES

Global Robot Grippers Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Single User, Electronic